Newsroom

Recent News Releases

May 29, 2020 5/29/2020

Takeda to Present Data from the ICLUSIG^® (ponatinib) Clinical Trial Program that Could Prove Practice-Changing for the Treatment of Chronic-Phase CML

May 29, 2020 5/29/2020

Takeda Announces Compelling Data from the Phase 2 Trial of Pevonedistat Plus Azacitidine in Patients with Higher-Risk MDS

May 29, 2020 5/29/2020

Takeda Receives Positive CHMP Opinion for Pre-filled Syringe Presentation of TAKHZYRO^® (lanadelumab) for use as a Preventive Treatment for Hereditary Angioedema Attacks

May 28, 2020 5/28/2020

European Commission Releases Takeda from Commitment to Divest Shire’s Pipeline Compound SHP647

May 26, 2020 5/26/2020

Racing Against Time, Medical Researchers, Life Science Companies and COVID-19 Survivors Launch National Campaign to Drive Blood Plasma Donation

SEE ALL NEWS AND RELEASES >

・For Shire news releases, click here

Featured Topics

Guided by Our Values: Supporting Global COVID-19 Response

Learn more

A ‘Swiss Cheese’ Approach Can Give Us a Second Chance to Contain COVID-19

Learn more

Empowering Ethnic Minorities to Improve Maternal and Newborn Health in Myanmar

Learn more

COVID-19: Working Together to Go Faster for Patients

Learn more

Coronavirus: Adjusting Our Business Approach While Serving Our Patients

Learn more

SEE ALL FEATURED TOPICS ARTICLES >

In the News

With this new original series featured in Asahi Shimbun Globe, President & CEO Christophe Weber gives his unique perspective on what he has learned from his upbringing in France and his international career.

LEARN MORE

Executive Leadership

Meet our Executive Leadership Team led by our President and CEO, Christophe Weber

LEARN MORE

For media inquiries or reporter requests for more information, contact our Corporate Communications via Media_Relations@takeda.com. If you generally would like to contact us, please visit Contact Us.